Anders Widmark

Research qualifications: Docent

Contact

Works at

Affiliated as other position at Department of Diagnostics and Intervention Section: Oncology

27C, Målpunkt QC11, NUS, NUS Umeå universitet, 901 85 Umeå

Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging

Physics and Imaging in Radiation Oncology, Elsevier 2024, Vol. 31

Grefve, Josefine; Söderkvist, Karin; Gunnlaugsson, Adalsteinn; et al.

Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer

Acta Oncologica, MJS Publishing, Medical Journals Sweden 2024, Vol. 63 : 503-510

Zarei, Maryam; Wallstén, Elin; Grefve, Josefine; et al.

Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study

Radiation Oncology, BioMed Central (BMC) 2023, Vol. 18, (1)

Björeland, Ulrika; Notstam, Kristina; Fransson, Per; et al.

Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)

Acta Oncologica, Taylor & Francis 2023, Vol. 62, (4) : 372-380

Josefsson, Andreas; Jellvert, Åsa; Holmberg, Erik; et al.

Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328

Cancers, MDPI 2023, Vol. 15, (9)

Järemo, Helena; Semenas, Julius; Halin Bergström, Sofia; et al.

The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography

Communications Medicine, Springer Nature 2023, Vol. 3, (1)

Nilsson, Erik; Sandgren, Kristina; Grefve, Josefine; et al.

Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [⁶⁸Ga]PSMA-11-PET and [¹¹C]Acetate-PET

Nuclear medicine communications, Lippincott Williams & Wilkins 2023, Vol. 44, (11) : 997-1004

Sandgren, Kristina; Strandberg, Sara; Jonsson, Joakim; et al.

Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C

Molecular Oncology, John Wiley & Sons 2022, (4)

Thysell, Elin; Köhn, Linda; Semenas, Julius; et al.

Epithelial and stromal characteristics of primary tumors predict the bone metastatic subtype of prostate cancer and patient survival after androgen-deprivation therapy

Cancers, MDPI 2022, Vol. 14, (21)

Wikström, Pernilla; Halin Bergström, Sofia; Josefsson, Andreas; et al.

A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer

Clinical Epigenetics, BioMed Central 2021, Vol. 13, (1)

Bovinder Ylitalo, Erik; Thysell, Elin; Landfors, Mattias; et al.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

The Lancet Oncology, Elsevier 2021, Vol. 22, (2) : 235-245

Fransson, Per; Nilsson, Per; Gunnlaugsson, Adalsteinn; et al.

Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo

The Prostate, John Wiley & Sons 2021, Vol. 81, (8) : 452-462

Hagberg Thulin, Malin; Määttä, Jorma; Linder, Anna; et al.

Registration of histopathology to magnetic resonance imaging of prostate cancer

Physics and Imaging in Radiation Oncology, Elsevier 2021, Vol. 18 : 19-25

Sandgren, Kristina; Nilsson, Erik; Keeratijarut Lindberg, Angsana; et al.

High monocyte count and expression of s100a9 and s100a12 in peripheral blood mononuclear cells are associated with poor outcome in patients with metastatic prostate cancer

Cancers, MDPI 2021, Vol. 13, (10)

Åberg, Anna-Maja; Halin Bergström, Sofia; Thysell, Elin; et al.

In Reply to Sari et al

International Journal of Radiation Oncology, Biology, Physics, Elsevier 2020, Vol. 107, (2) : 388-389

Aksnessaether, Bjorg Y.; Myklebus, Tor Age; Solberg, Arne; et al.

Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial

International Journal of Radiation Oncology, Biology, Physics, Elsevier 2020, Vol. 106, (4) : 706-714

Aksnessaether, Bjorg Y.; Myklebust, Tor Age; Solberg, Arne; et al.

Assessing Radiographic Response to ²²³Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients

Journal of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging 2020, Vol. 61, (5) : 671-675

Anand, Aseem; Tragardh, Elin; Edenbrandt, Lars; et al.

Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016

Acta Oncologica, Taylor & Francis 2020, Vol. 59, (5) : 549-557

Beckmann, Kerri; Garmo, Hans; Nilsson, Per; et al.

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens

The Prostate, John Wiley & Sons 2020, Vol. 80, (2) : 214-224

Bovinder Ylitalo, Erik; Thysell, Elin; Thellenberg-Karlsson, Camilla; et al.

Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study

JNCI CANCER SPECTRUM, Oxford University Press 2020, Vol. 4, (2)

Pettersson, Andreas; Alm, Daniel; Garmo, Hans; et al.

Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics, Elsevier 2020, Vol. 107, (1) : 143-151

Rasmusson, Elisabeth; Gunnlaugsson, Adalsteinn; Wieslander, Elinore; et al.

Tumor-educated platelets for early prostate cancer diagnosis, and therapy stratification in patients with metastasized castration resistant prostate cancer

Clinical Cancer Research, American Association for Cancer Research 2020, Vol. 26, (11) : 73-74

Tjon-Kon-Fat, Lee-Ann; Köhn, Linda; Best, Myron; et al.

Editorial Comment: Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

International Brazilian Journal of Urology, Vol. 46, (6) : 1100-1101

Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; et al.

Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiotherapy for Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics, Elsevier 2019, Vol. 105, (1) : S133-S134

Rasmusson, E.; Gunnlaugsson, A.; Wieslander, E.; et al.

Radiation dosimetry of [Ga-68]PSMA-11 in low-risk prostate cancer patients

EJNMMI Physics, Springer 2019, Vol. 6

Sandgren, Kristina; Johansson, Lennart; Axelsson, Jan; et al.

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

Molecular Oncology, John Wiley & Sons 2019, Vol. 13, (8) : 1763-1777

Thysell, Elin; Vidman, Linda; Bovinder Ylitalo, Erik; et al.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

The Lancet, Elsevier 2019, Vol. 394, (10196) : 385-395

Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; et al.

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial

JAMA Oncology, Vol. 4, (7) : 944-951

Armstrong, Andrew J.; Anand, Aseem; Edenbrandt, Lars; et al.

Bone remodeling in relation to androgen receptor activity in prostate cancer bone metastases

Cancer Research, American Association for Cancer Research 2018, Vol. 78, (16) : 50-50

Bovinder Ylitalo, Erik; Nordstrand, Annika; Thysell, Elin; et al.

The proteome of prostate cancer bone metastases

Cancer Research, American Association for Cancer Research 2018, Vol. 78, (16) : 91-92

Iglesias-Gato, Diego; Thysell, Elin; Crnalic, Sead; et al.

The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications

Clinical Cancer Research, American Association for Cancer Research 2018, Vol. 24, (21) : 5433-5444

Iglesias-Gato, Diego; Thysell, Elin; Tyanova, Stefka; et al.

Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor β (TGFβ) signaling

The Prostate, Vol. 78, (6) : 446-456

Karlsson, Terese; Sundar, Reshma; Widmark, Anders; et al.

Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity

International Journal of Molecular Sciences, MDPI 2018, Vol. 19, (4)

Nordstrand, Annika; Bovinder Ylitalo, Erik; Thysell, Elin; et al.

Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial

European Urology, Elsevier 2018, Vol. 73, (3) : 427-435

Parker, Christopher C.; Coleman, Robert E.; Sartor, Oliver; et al.

Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study

European Urology, Elsevier 2018, Vol. 73, (4) : 502-511

Robinson, David; Garmo, Hans; Lissbrant, Ingela Franck; et al.

Histology correlation of in vivo [68Ga]PSMA-PET/MRI data of the prostate

Radiotherapy and Oncology, Elsevier 2018, Vol. 127 : S541-S541

Sandgren, Kristina; Jonsson, Joakim; Nyholm, Tufve; et al.

Clinically relevant molecular subgroups of prostate cancer bone metastases

Cancer Research, American Association for Cancer Research 2018, Vol. 78, (16) : 123-123

Thysell, Elin; Bovinder Ylitalo, Erik; Jernberg, Emma; et al.

Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients

The Prostate, Wiley-Blackwell 2018, Vol. 78, (1) : 48-53

Tjon-Kon-Fat, Lee-Ann; Lundholm, Marie; Schröder, Mona; et al.

Ultrahypofractionation for prostate cancer: Outcome from the Scandinavian phase 3 HYPO-RT-PC trial

Radiotherapy and Oncology, Elsevier 2018, Vol. 127 : S314-S314

Widmark, Anders; Gunnlaugsson, A.; Beckman, Lars; et al.

Cabazitaxel followed by androgen deprivation therapy (ADT) significantly improves time to progression in patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A randomized, open label, phase III, multicenter trial

Annals of Oncology, Elsevier 2017, Vol. 28, (S5) : v281-v281

Andren, O.; Widmark, Anders; Falt, A.; et al.

Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events

International Journal of Radiation Oncology, Biology, Physics, Elsevier 2017, Vol. 97, (5) : 1026-1031

Bosco, Cecilia; Garmo, Hans; Adolfsson, Jan; et al.

Subgroups of castration-resistant prostate cancer bone metastases defined through an inverse relationship between androgen receptor activity and immune response

European Urology, Vol. 71, (5) : 776-787

Bovinder Ylitalo, Erik; Thysell, Elin; Jernberg, Emma; et al.

High Levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases

The Prostate, Wiley-Blackwell Publishing Inc. 2017, Vol. 77, (6) : 625-638

Djusberg, Erik; Jernberg, Emma; Thysell, Elin; et al.

Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone

Clinical and Experimental Metastasis, Springer 2017, Vol. 34, (3-4) : 261-271

Nordstrand, Annika; Halin Bergström, Sofia; Thysell, Elin; et al.

Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy

European Urology, Elsevier 2017, Vol. 72, (3) : 345-351

Sooriakumaran, Prasanna; Nyberg, Tommy; Akre, Olof; et al.

Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial

Clinical Genitourinary Cancer, CIG MEDIA GROUP, LP 2017, Vol. 15, (1) : 42-52

Vogelzang, Nicholas J.; Coleman, Robert E.; Michalski, Jeff M.; et al.

Metastatic spinal cord compression as the first sign of malignancy: Outcome after surgery in 69 patients

Acta Orthopaedica, Taylor & Francis 2017, Vol. 88, (4) : 457-462

Wänman, Johan; Grabowski, Pawel; Nyström, Helena; et al.

ATLAS: A phase 3 trial evaluating the efficacy of apalutamide (ARN-509) in patients with high-risk localized or locally advanced prostate cancer receiving primary radiation therapy

Annals of Oncology, Vol. 27

Bossi, A.; Dearnaley, D.; McKenzie, M.; et al.

Population-based study of long-term functional outcomes after prostate cancer treatment

BJU International, John Wiley & Sons 2016, Vol. 117, (6B) : E36-E45

Carlsson, Sigrid; Drevin, Linda; Loeb, Stacy; et al.

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7

European Urology, Vol. 70, (4) : 684-691

Fossa, Sophie D.; Wiklund, Fredrik; Klepp, Olbjorn; et al.

View publications in DiVA

Research groups

Group member

Per Fransson lab

Research projects

1 January 2022

PAMP (PSMA, Acetate and Multiparametric MRI for Prostate cancer)